Silicon Valley Bank has published an outstanding review of the Biotech market and yesterday with the Announcement that Bristol Myers is going to buy Celgene for a whooping $103 per share price, well the market just went crazy. Now is the time to invest in private equity, biotech's and of course, GLG Pharma is one of them!
The investment program ends on Jan 21, 2019 so now is the time. Go to Wefunder and look over the offering.
Here is the link to the Article!!! Biotech Article by SVB
We are revolutionizing patient drug combination screening for cancer. Gx-C3 combines Genetics of patients and cancer cells with Cancer Cell Capture, Culture and Chemistry!!